Skip to main content
WeightCited

Berberine для Metabolic Syndrome

A Доказательства Несколько крупных клинических испытаний стабильно демонстрируют значительные преимущества.

Meta-analysis of 12 RCTs (n=1,068) found significant reductions in body weight (2.07 kg), BMI, waist circumference, and triglycerides. Berberine addresses multiple metabolic syndrome components simultaneously through AMPK activation.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Dberberine\u0026condition\u003Dmetabolic\u002Dsyndrome'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Итог

Meta-analysis of 12 RCTs (n=1,068) found significant reductions in body weight (2.07 kg), BMI, waist circumference, and triglycerides. Berberine addresses multiple metabolic syndrome components simultaneously through AMPK activation.

Key Study Findings

Other 6 weeks
Berberine alleviates metabolic dysfunction-associated steatohepatitis by enhancing the abundance of Akkermansia muciniphila.
Dose: None или: MCD diet MASH model; Abx + FMT experiments Outcome: Hepatic/colonic inflammation, Akkermansia abundance Эффект: None None

Популяция: MCD diet-induced MASH C57BL/6J male mice

Other
The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with …
Dose: None или: None Outcome: None Эффект: None None

Популяция: None

Systematic Review n=61
Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review.
Dose: None или: None Outcome: None Эффект: None None

Популяция: Alzheimer's disease patients

Key Statistics

12

Исследования

1068

Участники

Positive

A

Оценка

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Часто используемые дозировки

general:
500 mg 2-3x/day with meals
starting:
500 mg/day and titrate
metabolicsupport:
1,000-1,500 mg/day

Верхний предел: 1,500 mg/day; GI side effects limit intake; potential drug interactions

Дозировки, изученные в исследованиях

Дозировка Длительность Эффект N
None 6 weeks Positive --
None -- Mixed --
None -- Positive 61

Лучшее время приёма: With meals (reduces GI discomfort and synchronizes with postprandial glucose metabolism)

Safety & Side Effects

Зарегистрированные побочные эффекты

  • Diarrhea
  • Constipation
  • Flatulence
  • Abdominal pain
  • Potential hypoglycemia (when combined with diabetes medications)

Известные взаимодействия

  • Diabetes medications (may potentiate — hypoglycemia risk)
  • CYP3A4 substrates (berberine is a CYP3A4 inhibitor)
  • CYP2D6 substrates
  • Cyclosporine
  • Metformin (additive effects)

Допустимый верхний уровень потребления: 1,500 mg/day; GI side effects limit intake; potential drug interactions

Всегда консультируйтесь с врачом перед началом приёма любых добавок.Всегда консультируйтесь с лечащим врачом перед началом приёма любой добавки.

Frequently Asked Questions

Does Berberine help with Metabolic Syndrome?
Based on 12 studies with 1,068 participants, there is strong evidence from multiple clinical trials that Berberine may support Metabolic Syndrome management. Our evidence grade is A (Strong Evidence).
How much Berberine should I take for Metabolic Syndrome?
Studies have used various dosages. A commonly studied range is 500 mg 2-3x/day with meals. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Berberine?
Reported side effects may include Diarrhea, Constipation, Flatulence, Abdominal pain. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Berberine and Metabolic Syndrome?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 12 peer-reviewed studies with 1,068 total participants. The overall direction of effect is positive.

Другие ингредиенты для Metabolic Syndrome

Berberine для других состояний

References

  1. [1] Jiahui Xu et al.. J Nutr Biochem. 2025. Berberine alleviates metabolic dysfunction-associated steatohepatitis by enhancing the abundance of Akkermansia muciniphila. doi:10.1016/j.jnutbio.2025.110069 PubMed
  2. [2] Yufan Dai et al.. Braz J Med Biol Res. 2022. The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with modulation of gut microbiota in … doi:10.1590/1414-431X2022e12096 PubMed
  3. [3] Noriko Shinjyo et al.. J Integr Med. 2020. Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review. doi:10.1016/j.joim.2020.01.004 PubMed

Отказ от ответственности FDA: Данные утверждения не были оценены Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов (FDA). Продукты и информация на этом сайте не предназначены для диагностики, лечения, излечения или профилактики каких-либо заболеваний. Представленные оценки доказательности основаны на нашем анализе опубликованных рецензируемых исследований и не являются медицинской консультацией. Всегда консультируйтесь с лечащим врачом перед началом приёма любых добавок.